MDGL - CIK 0001157601
MADRIGAL PHARMACEUTICALS, INC. has filed 1,184 documents with the SEC between 2002 and 2026. The most frequent type is insider trade (468 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider sale notice | 144 | 2024-06-14 | - |
| Insider sale notice | 144 | 2024-06-14 | - |
| Insider trade | 4 | 2024-06-14 | 2024-06-12 |
| Insider sale notice | 144 | 2024-06-13 | - |
| Insider trade | 4 | 2024-06-13 | 2024-06-11 |
| Insider sale notice | 144 | 2024-06-12 | - |
| Insider sale notice | 144 | 2024-06-11 | - |
| Insider sale notice | 144 | 2024-06-06 | - |
| Insider trade | 4 | 2024-05-23 | 2024-05-21 |
| Insider trade | 4 | 2024-05-16 | 2024-05-14 |
| Insider sale notice | 144 | 2024-05-14 | - |
| Quarterly report | 10-Q | 2024-05-07 | 2024-03-31 |
| Major company event | 8-K | 2024-05-07 | 2024-05-07 |
| 424B3 | - | 2024-05-07 | - |
| Prospectus supplement | 424B5 | 2024-05-07 | - |
| S-3ASR | - | 2024-05-07 | - |
| Major company event | 8-K | 2024-05-07 | 2024-05-07 |
| Annual report to shareholders | ARS | 2024-04-29 | 2023-12-31 |
| Proxy materials | DEFA14A | 2024-04-29 | - |
| Proxy statement | DEF 14A | 2024-04-29 | 2024-06-25 |
| Insider trade | 4 | 2024-04-10 | 2024-04-08 |
| Insider trade | 4 | 2024-04-10 | 2024-04-08 |
| Insider trade | 4 | 2024-04-05 | 2024-04-03 |
| Insider trade | 4 | 2024-04-05 | 2024-04-03 |
| Insider sale notice | 144 | 2024-04-03 | - |
| Insider sale notice | 144 | 2024-04-03 | - |
| Insider trade | 4 | 2024-04-03 | 2024-04-01 |
| Insider trade | 4 | 2024-04-03 | 2024-04-01 |
| Insider trade | 4 | 2024-04-03 | 2024-04-01 |
| Major company event | 8-K | 2024-04-02 | 2024-03-27 |
| Insider sale notice | 144 | 2024-04-01 | - |
| Insider sale notice | 144 | 2024-04-01 | - |
| Insider sale notice | 144 | 2024-04-01 | - |
| Activist ownership stake (update) | SC 13D/A | 2024-03-25 | - |
| Insider trade | 4 | 2024-03-25 | 2024-03-21 |
| New insider ownership | 3 | 2024-03-21 | 2024-03-11 |
| Major company event | 8-K | 2024-03-20 | 2024-03-18 |
| Prospectus supplement | 424B5 | 2024-03-20 | - |
| Prospectus supplement | 424B5 | 2024-03-18 | - |
| Major company event | 8-K | 2024-03-15 | 2024-03-14 |
| Annual report | 10-K | 2024-02-28 | 2023-12-31 |
| Major company event | 8-K | 2024-02-28 | 2024-02-22 |
| Major company event | 8-K | 2024-02-28 | 2024-02-28 |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-13 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-01-29 | - |
| Insider trade | 4 | 2024-01-25 | 2024-01-23 |
| Insider trade | 4 | 2024-01-25 | 2024-01-23 |